Recombinant GM-CSF in patients with poor graft function after bone marrow transplantation. | Clin Invest Med;13(2): 77-81, 1990 Apr. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Recombinant GM-CSF in patients with poor graft function after bone marrow transplantation.

Klingemann, H G; Eaves, A C; Barnett, M J; Reece, D E; Shepherd, J D; Belch, A R; Brandwein, J M; Langleben, A; Koch, P A; Phillips, G L.

Affiliation

Klingemann HG; Division of Hematology, Vancouver General Hospital, British Columbia.

Clin Invest Med ; 13(2): 77-81, 1990 Apr.

Article in En | MEDLINE | ID: mdl-2191816

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Proteins / Bone Marrow Transplantation / Colony-Stimulating Factors / Growth Substances Limits: Adolescent / Adult / Child / Humans / Middle aged Language: En Journal: Clin Invest Med Year: 1990 Document type: Article Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Proteins / Bone Marrow Transplantation / Colony-Stimulating Factors / Growth Substances Limits: Adolescent / Adult / Child / Humans / Middle aged Language: En Journal: Clin Invest Med Year: 1990 Document type: Article Country of publication: